Suppr超能文献

慢性伤口生物膜非传统抗菌方法的最新进展:我们找到“软肋”了吗?

Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the 'Chink in the Armor'?

作者信息

Kadam Snehal, Shai Saptarsi, Shahane Aditi, Kaushik Karishma S

机构信息

Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Pune 411045, India.

Poona College of Pharmacy, Bharati Vidyapeeth Deemed (to be) University, Erandwane, Pune 411038, India.

出版信息

Biomedicines. 2019 Apr 30;7(2):35. doi: 10.3390/biomedicines7020035.

Abstract

Chronic wounds are a major healthcare burden, with huge public health and economic impact. Microbial infections are the single most important cause of chronic, non-healing wounds. Chronic wound infections typically form biofilms, which are notoriously recalcitrant to conventional antibiotics. This prompts the need for alternative or adjunct 'anti-biofilm' approaches, notably those that account for the unique chronic wound biofilm microenvironment. In this review, we discuss the recent advances in non-conventional antimicrobial approaches for chronic wound biofilms, looking beyond standard antibiotic therapies. These non-conventional strategies are discussed under three groups. The first group focuses on treatment approaches that directly kill or inhibit microbes in chronic wound biofilms, using mechanisms or delivery strategies distinct from antibiotics. The second group discusses antimicrobial approaches that modify the biological, chemical or biophysical parameters in the chronic wound microenvironment, which in turn enables the disruption and removal of biofilms. Finally, therapeutic approaches that affect both, biofilm bacteria and microenvironment factors, are discussed. Understanding the advantages and limitations of these recent approaches, their stage of development and role in biofilm management, could lead to new treatment paradigms for chronic wound infections. Towards this end, we discuss the possibility that non-conventional antimicrobial therapeutics and targets could expose the 'chink in the armor' of chronic wound biofilms, thereby providing much-needed alternative or adjunct strategies for wound infection management.

摘要

慢性伤口是一项重大的医疗负担,对公共卫生和经济有着巨大影响。微生物感染是慢性难愈合伤口的最重要单一原因。慢性伤口感染通常会形成生物膜,而传统抗生素对生物膜的治疗效果 notoriously recalcitrant 。这促使人们需要替代或辅助的“抗生物膜”方法,尤其是那些考虑到慢性伤口生物膜独特微环境的方法。在本综述中,我们讨论了针对慢性伤口生物膜的非常规抗菌方法的最新进展,超越了标准抗生素疗法。这些非常规策略分为三类进行讨论。第一类重点关注直接杀死或抑制慢性伤口生物膜中微生物的治疗方法,其使用的机制或递送策略不同于抗生素。第二类讨论了改变慢性伤口微环境中的生物学、化学或生物物理参数的抗菌方法,这反过来又能破坏和清除生物膜。最后,讨论了同时影响生物膜细菌和微环境因素的治疗方法。了解这些最新方法的优点和局限性、它们的发展阶段以及在生物膜管理中的作用,可能会带来慢性伤口感染的新治疗模式。为此,我们讨论了非常规抗菌疗法和靶点可能揭示慢性伤口生物膜“弱点”的可能性,从而为伤口感染管理提供急需的替代或辅助策略。

相似文献

3
Nanocoatings for Chronic Wound Repair-Modulation of Microbial Colonization and Biofilm Formation.
Int J Mol Sci. 2018 Apr 12;19(4):1179. doi: 10.3390/ijms19041179.
4
Bioengineered Platforms for Chronic Wound Infection Studies: How Can We Make Them More Human-Relevant?
Front Bioeng Biotechnol. 2019 Dec 13;7:418. doi: 10.3389/fbioe.2019.00418. eCollection 2019.
5
Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.
IEEE Trans Nanobioscience. 2016 Apr;15(3):294-304. doi: 10.1109/TNB.2016.2527600. Epub 2016 Mar 2.
6
Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound.
Nanomaterials (Basel). 2022 Feb 25;12(5):778. doi: 10.3390/nano12050778.
7
Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms.
Wound Repair Regen. 2011 Jan-Feb;19(1):1-9. doi: 10.1111/j.1524-475X.2010.00651.x.
9
Microenvironment and microbiology of skin wounds: the role of bacterial biofilms and related factors.
Semin Vasc Surg. 2015 Sep-Dec;28(3-4):151-9. doi: 10.1053/j.semvascsurg.2016.01.003. Epub 2016 Jan 21.
10
Biofilms in Chronic Wounds: Pathogenesis and Diagnosis.
Trends Biotechnol. 2019 May;37(5):505-517. doi: 10.1016/j.tibtech.2018.10.011. Epub 2018 Nov 26.

引用本文的文献

1
Post-vitrectomy endophthalmitis complicated with orbital cellulitis treated with hyperbaric oxygen therapy: A case report.
Medicine (Baltimore). 2025 Apr 4;104(14):e42043. doi: 10.1097/MD.0000000000042043.
2
Comparative Genomic Analysis of 66 Bacteriophages Infecting Morganella morganii Strains.
Curr Microbiol. 2025 Feb 15;82(4):137. doi: 10.1007/s00284-025-04110-7.
3
Evaluation of the antibacterial properties of four bioactive biomaterials for chronic wound management.
Future Microbiol. 2025 Feb;20(3):247-258. doi: 10.1080/17460913.2025.2453334. Epub 2025 Jan 15.
6
Unravelling the Microbiome's Role in Healing Diabetic Wounds.
Curr Pharm Biotechnol. 2024 Jun 12. doi: 10.2174/0113892010307032240530071003.
8
Biofilm therapy for chronic wounds.
Int Wound J. 2024 Feb;21(2):e14667. doi: 10.1111/iwj.14667.
9
The Effect of Mesenchymal Stem Cells on the Wound Infection.
Curr Stem Cell Res Ther. 2024;19(8):1084-1092. doi: 10.2174/011574888X252482230926104342.
10
Postbiotic as Novel Alternative Agent or Adjuvant for the Common Antibiotic Utilized in the Food Industry.
Curr Pharm Biotechnol. 2024;25(10):1245-1263. doi: 10.2174/1389201025666230912123849.

本文引用的文献

1
Itaconimides as Novel Quorum Sensing Inhibitors of .
Front Cell Infect Microbiol. 2019 Jan 7;8:443. doi: 10.3389/fcimb.2018.00443. eCollection 2018.
2
Potential Properties of Lactobacillus plantarum F-10 as a Bio-control Strategy for Wound Infections.
Probiotics Antimicrob Proteins. 2019 Dec;11(4):1110-1123. doi: 10.1007/s12602-018-9486-8.
3
Chlorogenic acid attenuates virulence factors and pathogenicity of Pseudomonas aeruginosa by regulating quorum sensing.
Appl Microbiol Biotechnol. 2019 Jan;103(2):903-915. doi: 10.1007/s00253-018-9482-7. Epub 2018 Nov 12.
4
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
Front Cell Infect Microbiol. 2018 Oct 23;8:376. doi: 10.3389/fcimb.2018.00376. eCollection 2018.
5
Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections.
Biomed Pharmacother. 2019 Jan;109:440-447. doi: 10.1016/j.biopha.2018.10.142. Epub 2018 Nov 3.
8
Treatment Strategies for Infected Wounds.
Molecules. 2018 Sep 18;23(9):2392. doi: 10.3390/molecules23092392.
9
Antimicrobial effects of mesenchymal stem cells primed by modified LPS on bacterial clearance in sepsis.
J Cell Physiol. 2019 Apr;234(4):4970-4986. doi: 10.1002/jcp.27298. Epub 2018 Sep 14.
10
Coumarin Reduces Virulence and Biofilm Formation in by Affecting Quorum Sensing, Type III Secretion and C-di-GMP Levels.
Front Microbiol. 2018 Aug 21;9:1952. doi: 10.3389/fmicb.2018.01952. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验